CSNK2A2
Casein kinase II subunit alpha'
Also known as: CK2alpha', CSK22_HUMAN, CSNK2A1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P19784
- Gene
- CSNK2A2
- Ensembl
- ENSG00000070770
- Chromosome
- 16
- Canonical length
- 350 aa
- Protein class
- Cancer-related genes, Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes the alpha', or alpha 2, catalytic subunit of the protein kinase enzyme, casein kinase 2 (CK2). Casein kinase 2 is a serine/threonine protein kinase that phosphorylates acidic proteins such as casein. It is involved in various cellular processes, including cell cycle control, apoptosis, and circadian rhythms. This heterotetrameric kinase includes two catalytic subunits, either alpha or alpha', and two regulatory beta subunits. The closely related gene paralog encoding the alpha, or alpha 1 subunit (CSNK2A1, Gene ID: 1457) is found on chromosome 20. An intronic variant in this gene (alpha 2) may be associated with leukocyte telomere length in a South Asian population. A related transcribed pseudogene is found on chromosome 11. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
350 residues, UniProt reviewed canonical sequence.
>P19784|CSNK2A2
1 MPGPAAGSRA RVYAEVNSLR SREYWDYEAH VPSWGNQDDY QLVRKLGRGK YSEVFEAINI
61 TNNERVVVKI LKPVKKKKIK REVKILENLR GGTNIIKLID TVKDPVSKTP ALVFEYINNT
121 DFKQLYQILT DFDIRFYMYE LLKALDYCHS KGIMHRDVKP HNVMIDHQQK KLRLIDWGLA
181 EFYHPAQEYN VRVASRYFKG PELLVDYQMY DYSLDMWSLG CMLASMIFRR EPFFHGQDNY
241 DQLVRIAKVL GTEELYGYLK KYHIDLDPHF NDILGQHSRK RWENFIHSEN RHLVSPEALD
301 LLDKLLRYDH QQRLTAKEAM EHPYFYPVVK EQSQPCADNA VLSSGLTAARLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CSNK2A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 114 nTPM
Expression across tissuesHPA
Tissue
- testis: 114 nTPM
- skin: 64 nTPM
- skeletal muscle: 41 nTPM
- pancreas: 37 nTPM
- colon: 32 nTPM
- choroid plexus: 30 nTPM
Single-cell type
- late spermatids: 405 nCPM
- early spermatids: 289 nCPM
- late primary spermatocytes: 103 nCPM
- choroid plexus epithelial cells: 87 nCPM
- pancreatic acinar cells: 72 nCPM
- urothelial cells: 68 nCPM
Immune cell
- plasmacytoid DC: 2 nTPM
- naive CD4 T-cell: 1.8 nTPM
- naive CD8 T-cell: 1.3 nTPM
- basophil: 1.1 nTPM
- memory CD4 T-cell: 1.1 nTPM
- gdT-cell: 0.7 nTPM
Brain region
- choroid plexus: 22 nTPM
- midbrain: 15 nTPM
- cerebral cortex: 15 nTPM
- thalamus: 15 nTPM
- basal ganglia: 14 nTPM
- white matter: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.15
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cerebral cortex development
- DNA damage response
- double-strand break repair
- liver regeneration
- negative regulation of apoptotic signaling pathway
- negative regulation of proteasomal ubiquitin-dependent protein catabolic process
- positive regulation of protein targeting to mitochondrion
- regulation of chromosome separation
- regulation of mitophagy
- spermatogenesis
- Wnt signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CSNK2A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CSNK2A2 as an antibody target. Whether an autoantibody or antibody against CSNK2A2 could matter depends on whether native CSNK2A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CSNK2A2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CSNK2A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...